ClinicalTrials.gov
public full text
Public Domain
Creatine Therapy for Huntington's Disease
This study, CREST-HD, will examine the safety and tolerability of 8 grams of creatine in subjects affected by Huntington's disease (HD). Biochemistry and neuroimaging will be used to examine the potential effects of creatine on HD.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Creatine Safety & Tolerability in Huntington's Disease#810165
- An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196#896852
- Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease#1140550
- Pilot Study of Minocycline in Huntington's Disease#874265
- Ursodiol in Huntington's Disease#1137312
Record · ID 1137582
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive